Genetics of Familial and Sporadic ALS (ALS)
Identification of Genes Causing Familial ALS or Increasing Risk for Sporadic ALS and ALS With Frontotemporal Dementia and Understanding Disease Mechanism.
Sponsor: Northwestern University
Listed as NCT00821132, this observational or N/A phase trial focuses on ALS With Frontotemporal Dementia (ALS/FTD) and Amyotrophic Lateral Sclerosis (ALS) and remains completed. Sponsored by Northwestern University, it has been updated 13 times since 1991, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Dec 2021 — Feb 2023 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2019 — Oct 2020 [monthly]
Recruiting
-
Jun 2018 — Sep 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 1991
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Northwestern University
For direct contact, visit the study record on ClinicalTrials.gov .